Germline pot1 deregulation can predispose to myeloid malignancies in childhood

Pia Michler, Anne Schedel, Martha Witschas, Ulrike Anne Friedrich, Rabea Wagener, Juha Mehtonen, Triantafyllia Brozou, Maria Menzel, Carolin Walter, Dalileh Nabi, Glen Pearce, Miriam Erlacher, Gudrun Göhring, Martin Dugas, Merja Heinäniemi, Arndt Borkhardt, Friedrich Stölzel, Julia Hauer, Franziska Auer

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

While the shelterin complex guards and coordinates the mechanism of telomere regulation, deregulation of this process is tightly linked to malignant transformation and cancer. Here, we present the novel finding of a germline stop-gain variant (p.Q199*) in the shelterin complex gene POT1, which was identified in a child with acute myeloid leukemia. We show that the cells overexpressing the mutated POT1 display increased DNA damage and chromosomal instabilities compared to the wildtype counterpart. Protein and mRNA expression analyses in the primary patient cells further confirm that, physiologically, the variant leads to a nonfunctional POT1 allele in the patient. Subsequent telomere length measurements in the primary cells carrying heterozygous POT1 p.Q199* as well as POT1 knockdown AML cells revealed telomeric elongation as the main functional effect. These results show a connection between POT1 p.Q199* and telomeric dysregulation and highlight POT1 germline deficiency as a predisposition to myeloid malignancies in childhood.

Original languageEnglish
Article number11572
JournalInternational Journal of Molecular Sciences
Volume22
Issue number21
DOIs
StatePublished - 1 Nov 2021
Externally publishedYes

Keywords

  • Acute myeloid leukemia
  • Germline cancer predisposition
  • POT1
  • Pediatric
  • Shelterin complex
  • Trio sequencing

Fingerprint

Dive into the research topics of 'Germline pot1 deregulation can predispose to myeloid malignancies in childhood'. Together they form a unique fingerprint.

Cite this